FDA Inspection 666879 — Statline (Division Of MTF Biologics)

Statline (Division Of MTF Biologics) — FEI 3003447829

The FDA completed an inspection of Statline (Division Of MTF Biologics) on Jun 11, 2010 in Edison, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 11, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Edison, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.